Enhanced induction of apoptosis of human gastric carcinoma cells after preoperative treatment with 5-fluorouracil

Cancer

Volumn 79, Issue 1, 1997, Pages 12-17

  Sugamura, Kenji ^a   Makino, Masato ^a   Shirai, Hiroyuki ^a   Kimura, Osamu ^a   Maeta, Michio ^a   Itoh, Hisao ^a   Kaibara, Nobuaki ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

5 fluorouracil; apoptosis; Bax; human gastric carcinoma; Ki 67

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; KI 67 ANTIGEN; PROTEIN BAX;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; STOMACH CARCINOMA;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; CARCINOMA; FEMALE; FLUOROURACIL; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0031033362     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970101)79:1<12::AID-CNCR3>3.0.CO;2-O     Document Type: Article

References (25)

1. Wyllie AH. Apoptosis (The 1992 Frank Rose Memorial Lecture). Br J Cancer 1993;67:205-8.
2. Williams GT. Programmed cell death: apoptosis and oncogenesis. Cell 1991;65:1097-8.
3. Eastman A. Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells 1990; 2:275-80.
4. Walton MI, Whysong D, O' Connor PM, Hockenbery D, Korsmeyer SJ, Kohn KW. Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis. Cancer Res 1993;53:1853-61.
5. Barry MA, Reynolds JE, Eastman A. Etoposide-induced apoptosis in human HL-60 cells is associated with intracellular acidification. Cancer Res 1993;53:2349-57.
6. Gorczyca W, Gong J, Ardelt B, Traganos F, Darzynkiewicz Z. The cell cycle-related difference in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res 1993;53:3186-92.
7. Makino M, Shirai H, Sugamura K, Kimura O, Maeta M, Itoh H, et al. Increased apoptosis of human colorectal cancer cells after preoperative treatment with 5-fluorouracil. Oncol Rep 1996;3:281-5.
8. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
9. Yin XM, Oltvai ZN, Korsmeyer SJ. BH1 and BH2 domains of bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 1994;369:321-33.
10. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-19.
11. Hsu S-M, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
12. Shan-Rong S, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991; 39:741-8.
13. Wisman JH, Jonker RR, Keijzer R, Van DeVelde CJH, Cornelisse CJ, Van Dierendonck JH. A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem 1993;41:7-12.
14. Ansari B, Coates PJ, Greenstein BD, Hall PA. In situ end-labeling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol 1993;170:1-8.
15. Kasagi N, Gomyo Y, Shirai H, Tsujitani S, Ito H. Apoptotic cell death in human gastric carcinoma: analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling. Jpn J Cancer Res 1994;85:939-45.
16. Saegusa M, Takano Y, Wakabayashi T, Okayasu I. Apoptosis in gastric carcinomas and its association with cell proliferation and differentiation. Jpn J Cancer Res 1994;86:743-8.
17. Miyashita T, Krajewski S, Krajewska M, Wang HG, Link HK, Hoffman B, et al. Tumor suppressor p53 is a regulator of bcl-2 and Bax in gene expression in vitro and in vivo. Oncogene 1994;9:1799-805.
18. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of human Bax gene. Cell 1995;80: 293-9.
19. Krajewski S, Blomqvist C, Franssila K, Krajewska M, Wasenius VM, Niskanen E, et al. Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res 1995; 55:4471-8.
20. Key G, Becher MHG, Duchrow M, Schluter C, Gerdes J. New Ki-67 equivalent murine monoclonal antibodies (MIB-1-3) prepared against recombinant parts of Ki-67 antigen. Anal Cell Pathol 1992;4:181.
21. Barry MA, Behnke CA, Eastman A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 1990;40:2353-62.
22. Ijiri K, Potten CS. Further studies on the response of intestinal crypt cells of different hierarchical status to eighteen different cytotoxic agents. Br J Cancer 1987;55:113-23.
23. Sakaguchi Y, Stephens LC, Makino M, Kaneko T, Strebel FR, Danhauser LL, et al. Apoptosis in normal tissues induced by 5-fluorouracil:comparison between bolus injection and prolonged infusion. Anticancer Res 1994;14:1489-92.
24. Zubrod CG. Effect of 5-fluorouracil and 5-fluorodexyuridine on gastrointestinal cancer. JAMA 1961;25:832-4.
25. Izumi M, Ohwada S, Morishita Y. Evaluation of continuous intravenous infusion with 5-fluorouracil for advanced or recurrent gastric and colorectal cancer. J Jpn Cancer Ther 1995;30:24-9.